GLOBAL GLUTATHIONE MARKET SIZE, BY PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION) TABLE 186
Lilly has confirmed that seven additional Phase 3 readouts are anticipated through the rest of 2026, covering further obesity, type 2 diabetes, sleep apnoea, and maintenance dosing studies
It has been used off-label for weight loss, with growing interest in its formal approval for obesity treatment
Each persons health journey is unique, and the support of data-driven insights can empower us to make the best decisions for our own lives
9 Reactions at the injection site have also been reported
- Side effects of carnitine supplementation are infrequent and usually mild